Curaleaf Holdings Inc Stock News

Multi-state cannabis operators Curalef Holdings Inc., Trulieve Cannabis Corp. and Verano Holdings Corp. will get a boost if the U.S. reclassifies cannabis as a Schedule III drug from its current Sched

Investing in the best marijuana stocks can be a challenge at times. For example, you would think the company whos more successful would do better in the stock market. With the cannabis sector that is

The growing use cases for cannabis and hemp for medical and other purposes and the release of X's Grok AI have led to this list of Grok AI cannabis stock picks. Grok AI is trained on tweet data and ha

Marijuana stock investors are staying as optimistic as they can. With 2024 just starting there is much to look forward to. We have the ongoing battle to pass some type of federal reform. 2024 is an el

With an ocean of listed companies in various stocks exchanges in the United States, it's not surprising that a few gems are not in the limelight. Further, there are stories that are ignored by the mar

The release of documents that support a recommendation by the U.S. Department of Health and Human Services to lower the classification of cannabis under federal law to Schedule III from Schedule I ign

So far marijuana stocks have slowly been having more market momentum. Much of this can be due to several factors that may continue to help. With the 2024 year just starting the anticipation of what's

According to industry analysts, the American cannabis market is expected to grow to $46.90 billion through 2027. This growth is due to several factors, such as an increase in the number of dispensarie

As we step into 2024, the U.S. marijuana industry and top marijuana stocks are buzzing with potential, making it a hot topic for investors. The landscape is changing rapidly, thanks to the growing acc

Facing pivotal changes, the medical marijuana stocks market, once considered self-reliant, is now recognizing the importance of customer engagement. In an era marked by inflation and price compression

Even with a relatively small portfolio allocation, penny stocks can have a big impact in terms of total portfolio returns. The reason is that when some of the hottest penny stocks surge, the rally is

There finally seems to be light at the end of the tunnel for the cannabis industry. It's difficult to talk about the regulatory perspective.

New York ended its first year of legal adult-use cannabis retail sales with about $150 million in revenue statewide, a relatively slow start for a fledgling regulated market that has been projected to

Boris Jordan, CuraLeaf Executive Chairman, joins 'Fast Money' to talk the cannabis sector heading into 2024.

The U.S. cannabis industry and top marijuana stocks are booming like never before, and it's not slowing down anytime soon. Picture this: in 2022, the industry was already worth a hefty $13.2 billion.